Infant mortality due to preventable causes
DOI:
https://doi.org/10.46311/2318-0579.59.eUJ4394Palabras clave:
Basic health indicators, cause of death, child mortality, descriptive epidemiologyResumen
Infant mortality refers to deaths of children under one year of age, subdivided into neonatal mortality (early and late neonatal) and post-neonatal mortality, being considered an indicator for assessing the population's health situation. The study aimed at describing the infant mortality rates due to preventable causes, in children under one year of age and in the state of Alagoas, during 2017. A descriptive and cross-sectional ecological study was carried out, with a quantitative approach on mortality rates in the age group of children under one year old, based on secondary data available in the Mortality Information System, by the Informatics Department of the Unified Health System (Departamento de Informática do Sistema Único de Saúde, [DATASUS]). This study was carried out from November to December 2019. During this period, in the state of Alagoas, 793 deaths due to preventable causes among children under five years of age were recorded in the Informatics Department of the Unified Health System. 83.98% (n=666) of these deaths corresponded to children under one year of age, with death cases in the early neonatal period being the most prevalent, followed by deaths in the post-neonatal and late neonatal periods. Among the cities in Alagoas, Maceió ranks first and Arapiraca is in second place in relation to the infant mortality rate.
Descargas
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2022 Revista Uningá
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
I declare/we declare that the text submitted here is original, of my own authorship and does not infringe any type of third party rights. The content is my/our sole responsibility. Possible research involving animals and/or human beings is in accordance with Resolution 196/96 of the National Health Council and its complements. I declare that I am/we are in possession of the written consent of patients and that the research and its procedures were timely and adequately approved by the Ethics Committee of the institution of origin. We further declare that all institutional affiliations and all sources of financial support for the work are duly informed. I certify that there is no commercial or associative interest that represents a conflict of interest related to the submitted work. If there is commercial interest, in addition to the technical and academic ones, in the publication of the article, the information will be reported during the text.
